Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Atavistik Bio, Inc
University of Kansas Medical Center
Seagen Inc.
M.D. Anderson Cancer Center
Sun Yat-sen University
University Health Network, Toronto
University Health Network, Toronto
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Duke University
M.D. Anderson Cancer Center
Arcus Biosciences, Inc.
Ascendis Pharma A/S
Qurient Co., Ltd.
Institut du Cancer de Montpellier - Val d'Aurelle
Institute of Cancer Research, United Kingdom
AbbVie
AstraZeneca